T1	CHEM 59 81	ácido acetilsalicílico
#1	AnnotatorNotes T1	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T2	PROC 87 95	prevenir
#2	AnnotatorNotes T2	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T3	DISO 96 123	complicaciones del embarazo
T4	LIVB 127 134	mujeres
#3	AnnotatorNotes T4	C0043210; Woman; Population Group | C0242665; wife; Family Group
T5	DISO 135 160	infectadas por SARS-CoV-2
T6	PROC 183 208	Evaluación de la eficacia
T7	CHEM 213 235	ácido acetilsalicílico
#4	AnnotatorNotes T7	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T8	Dose 238 249	dosis bajas
T9	PROC 256 266	prevención
#5	AnnotatorNotes T9	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T10	DISO 274 313	efectos maternos y perinatales adversos
T11	Date 282 290	maternos
T12	Date 293 304	perinatales
T13	LIVB 317 336	mujeres embarazadas
#6	AnnotatorNotes T13	C0033011; Pregnant Women; Population Group
T14	DISO 337 365	infectadas por el SARS-CoV-2
T15	DISO 389 413	Infección por SARS-CoV-2
#7	AnnotatorNotes T15	C5203670; COVID19 (disease); Disease or Syndrome
T16	LIVB 442 461	Mujeres embarazadas
#8	AnnotatorNotes T16	C0033011; Pregnant Women; Population Group
T17	Duration 468 482	las 32 semanas
T18	PROC 486 502	edad gestacional
T19	Age 505 523	Mayores de 18 años
T20	PHYS 541 544	luz
T21	PROC 604 615	tratamiento
#9	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	CHEM 628 631	AAS
#10	AnnotatorNotes T22	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T23	PROC 640 650	prevención
#11	AnnotatorNotes T23	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T24	DISO 657 669	preeclampsia
#12	AnnotatorNotes T24	C0032914; Pre-Eclampsia; Pathologic Function
T25	PROC 680 721	medicación antiinflamatoria no esteroidea
T26	Neg_cue 708 710	no
T27	Negated 711 721	esteroidea
T28	Date 722 735	a largo plazo
T29	DISO 738 761	Trastornos hemorrágicos
#13	AnnotatorNotes T29	C0019087; Hemorrhagic Disorders; Disease or Syndrome
T30	DISO 770 798	enfermedad de Von Willebrand
#14	AnnotatorNotes T30	C0042974; von Willebrand Disease; Disease or Syndrome
T31	DISO 817 835	ulceración péptica
#15	AnnotatorNotes T31	C0030920; Peptic Ulcer; Disease or Syndrome
T32	DISO 854 871	hipersensibilidad
#16	AnnotatorNotes T32	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding | C0585186; Cutaneous hypersensitivity; Disease or Syndrome
T33	CHEM 875 878	AAS
#17	AnnotatorNotes T33	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T34	PROC 903 917	ensayo clínico
#18	AnnotatorNotes T34	C0008976; Clinical Trials; Research Activity
T35	Neg_cue 920 936	Incapacidad para
T36	Negated 937 976	cooperar con los requisitos del estudio
T37	DISO 979 1008	Enfermedad grave por COVID-19
T38	PROC 1044 1067	frecuencia respiratoria
T39	DISO 1092 1115	dificultad respiratoria
#19	AnnotatorNotes T39	C0013404; Dyspnea; Sign or Symptom | C0476273; Respiratory distress; Sign or Symptom
T40	PROC 1123 1127	SpO2
T41	DISO 1153 1194	síndrome de dificultad respiratoria aguda
#20	AnnotatorNotes T41	C0035222; Respiratory Distress Syndrome, Adult; Disease or Syndrome
T42	DISO 1196 1202	sepsis
#21	AnnotatorNotes T42	C0243026; Sepsis; Disease or Syndrome
T43	DISO 1207 1232	disfunción orgánica aguda
T44	DISO 1237 1258	Hiperémesis gravídica
#22	AnnotatorNotes T44	C0020450; Hyperemesis Gravidarum; Sign or Symptom
T45	PROC 1273 1284	tratamiento
#23	AnnotatorNotes T45	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
